Oncology

Stopping ovarian cancer screening in BRCA1/2 mutation carriers: Effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens. PMID: 24530815

Krivak TC, Lele S, Richard S, Alvarez Secord A, Leath CA 3rd, Brower SL, Tian C, Moore RG.Am J Obstet Gynecol. 2014 Feb 12. [Epub ahead of print]pii: S0002-9378(14)00126-4. doi: 10.1016/j.ajog.2014.02.009.

Learn more Learn more
Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women’s Wellness Program. PMID: 25608273

Anderson DJ, Seib C, McCarthy AL, Yates P, Porter-Steele J, McGuire A, Young L.Menopause. 2015 Jan 20. [Epub ahead of print]

Learn more Learn more
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. PMID: 25677739

Yaghjyan L, Colditz GA, Rosner B, Tamimi RM.Breast Cancer Res Treat. 2015 Feb 13. [Epub ahead of print]

Learn more Learn more
Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors. PMID: 25690696

Lee M, Kim YH, Jeon MJ.Psychooncology. 2015 Feb 17. [Epub ahead of print]doi: 10.1002/pon.3772.

Learn more Learn more
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study. PMID: 25742479

Li K, Hüsing A, Fortner RT, Tjønneland A, Hansen L, et al.Br J Cancer. 2015 Mar 5. [Epub ahead of print]doi: 10.1038/bjc.2015.22.

Learn more Learn more
Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. PMID: 25754110

Caini S, Gibelli B, Palli D, Saieva C, Ruscica M, Gandini S.Cancer Causes Control. 2015 Apr;26(4):511-8. Epub 2015 Mar 10.doi: 10.1007/s10552-015-0546-z.

Learn more Learn more
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. PMID: 25888246

Strasser-Weippl K, Horick N, Smith IE, O’Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE.Breast Cancer Res. 2015 Apr 16;17(1):56. [Epub ahead of print]

Learn more Learn more
Long-term exposure to air pollution and mammographic density in the Danish Diet, Cancer and Health cohort. PMID: 25879829

Huynh S, von Euler-Chelpin M, Raaschou-Nielsen O, Hertel O, Tjønneland A, Lynge E, Vejborg I, Andersen ZJ.Environ Health. 2015 Apr 1;14(1):31.doi: 10.1186/s12940-015-0017-8.

Learn more Learn more
Self-reported memory problems in adult-onset cancer survivors: effects of cardiovascular disease and insomnia. PMID: 26026625

Jean-Pierre P, Grandner MA, Garland SN, Henry E, Jean-Louis G, Burish TG.Sleep Med. 2015 Mar 18.pii: S1389-9457(15)00643

Learn more Learn more
Occupational exposure to solvents and risk of breast cancer. PMID: 26010434

Glass DC, Heyworth J, Thomson AK, Peters S, Saunders C, Fritschi L.Am J Ind Med. 2015 May 26.doi: 10.1002/ajim.22478. [Epub ahead of print]

Learn more Learn more
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden PMID: 26082817

.Wendt C, Lindblom A, Arver B, von Wachenfeldt A, Margolin S.Hered Cancer Clin Pract. 2015 Jun 16;13(1):15. doi: 10.1186/s13053-015-0036-z. eCollection 2015.

Learn more Learn more
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. PMID: 26092816

Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA.Lancet Oncol. 2015 Jun 16. pii: S1470-2045(15)00049-2. doi: 10.1016/S1470-2045(15)00049-2. [Epub ahead of print]

Learn more Learn more
Laparoscopic and robot-assisted hysterectomy for uterine cancer: a comparison of costs and complications. PMID: 26188114

Zakhari A, Czuzoj-Shulman N, Spence AR, Gotlieb WH, Abenhaim HA.Am J Obstet Gynecol. 2015 Jul 15.pii: S0002-9378(15)00720-6. doi: 10.1016/j.ajog.2015.07.004. [Epub ahead of print]

Learn more Learn more
Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile PMID: 26151267

 RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.JAMA. 2015 Jul 7;314(1):61-71.doi: 10.1001/jama.2015.6789.

Learn more Learn more
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. PMID: 26296642

Zhang B, Shu XO, Delahanty RJ, et alJ Natl Cancer Inst. 2015 Aug 20;107(11).pii: djv219. doi: 10.1093/jnci/djv219. Print 2015 Nov.

Learn more Learn more
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up. PMID: 26298334

Majithia N, Atherton PJ, Lafky JM, Wagner-Johnston N, Olson J, Dakhil SR, Perez EA, Loprinzi CL, Hines SL.Support Care Cancer. 2015 Aug 23. [Epub ahead of print]

Learn more Learn more
Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance. PMID: 26386956

Peppercorn J, Houck K, Beri N, Villagra V, Wogu AF, Lyman GH, Wheeler SB.Breast Cancer Res Treat. 2015 Sep 19. [Epub ahead of print]

Learn more Learn more
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. PMID: 26387144

Munzone E, Giobbie-Hurder A, Gusterson BA, Mallon E, Viale G, Thürlimann B, Ejlertsen B, MacGrogan G, Bibeau F, Lelkaitis G, Price KN, Gelber RD, Coates AS, Goldhirsch A, Colleoni M; International Breast Cancer Study Group and the BIG 1-98 Collaborative Group.Ann Oncol. 2015 Sep 19.pii: mdv391. [Epub ahead of print]

Learn more Learn more
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. PMID: 26493647

Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR.Nat Rev Cancer. 2015 Oct 23;15(11):668-79.doi: 10.1038/nrc4019.

Learn more Learn more
Dietary exposure to cadmium and risk of breast cancer in postmenopausal women: A systematic review and meta-analysis. PMID: 26479829

Van Maele-Fabry G, Lombaert N, Lison D.Environ Int. 2015 Oct 16;86:1-13.doi: 10.1016/j.envint.2015.10.003. [Epub ahead of print] Review.

Learn more Learn more
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma. PMID: 26583357

Edelmann MN, Daryani VM, Bishop MW, Liu W, Brinkman TM, Stewart CF, Mulrooney DA, Kimberg C, Ness KK, Cheung YT, Srivastava DK, Robison LL, Hudson MM, Krull KR.JAMA Oncol. 2015 Nov 19:1-8.doi: 10.1001/jamaoncol.2015.4398. [Epub ahead of print]

Learn more Learn more
Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora’s Box? PMID: 26555236

Lawler M, Sullivan R.Public Health Genomics. 2015 Nov 11. [Epub ahead of print]

Learn more Learn more
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma. PMID: 26699166

Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.N Engl J Med. 2015 Dec 24;373(26):2499-511.doi: 10.1056/NEJMoa1505949.

Learn more Learn more
Trajectory of body shape across the lifespan and cancer risk. PMID: 26704725

Song M, Willett WC, Hu FB, Spiegelman D, Must A, Wu K, Chan AT, Giovannucci EL.Int J Cancer. 2015 Dec 24.doi: 10.1002/ijc.29981. [Epub ahead of print]

Learn more Learn more
The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates. PMID: 26800299

Gray N, Picone G.Health Serv Res. 2016 Jan 22.doi: 10.1111/1475-6773.12445. [Epub ahead of print]

Learn more Learn more
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. PMID: 26757170

Siu AL; U.S. Preventive Services Task Force.Ann Intern Med. 2016 Jan 12.doi: 10.7326/M15-2886. [Epub ahead of print]

Learn more Learn more
Cardiomyopathy Associated With Targeted Therapy for Breast Cancer. PMID: 26897275

Sivagnanam K, Rahman ZU, Paul T.Am J Med Sci. 2016 Feb;351(2):194-199.doi: 10.1016/j.amjms.2015.11.014.

Learn more Learn more
Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines. PMID: 26897719

Parisi MT, Eslamy H, Mankoff D.Semin Nucl Med. 2016 Mar;46(2):147-164.doi: 10.1053/j.semnuclmed.2015.10.006. Review.

Learn more Learn more
Associations of body mass index with cancer incidence among populations, genders, and menopausal status: A systematic review and meta-analysis. PMID: 26946037

Wang J, Yang DL, Chen ZZ, Gou BF.Cancer Epidemiol. 2016 Mar 3;42:1-8.doi: 10.1016/j.canep.2016.02.010. [Epub ahead of print]

Learn more Learn more
Identifying predictors of delayed diagnoses in symptomatic breast cancer: a scoping review. PMID: 26950652

Webber C, Jiang L, Grunfeld E, Groome PA.Eur J Cancer Care (Engl). 2016 Mar 7.doi: 10.1111/ecc.12483. [Epub ahead of print]

Learn more Learn more
Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer. PMID: 27097356

de Kort S, Simons CC, van den Brandt PA, Goldbohm RA, Arts IC, de Bruine AP, Janssen-Heijnen ML, Sanduleanu S, Masclee AA, Weijenberg MP.Eur J Gastroenterol Hepatol. 2016 Apr 19. [Epub ahead of print]

Learn more Learn more
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PMID: 27096951

Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, Kelson M, Dolwani S.PLoS One. 2016 Apr 20;11(4):e0152402.doi: 10.1371/journal.pone.0152402. eCollection 2016.

Learn more Learn more
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review. PMID: 27209246

Arts-de Jong M, de Bock GH, van Asperen CJ, Mourits MJ, de Hullu JA, Kets CM.Eur J Cancer. 2016 May 17;61:137-145.doi: 10.1016/j.ejca.2016.03.009. [Epub ahead of print] Review.

Learn more Learn more
Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women. PMID: 27190045

Yang HP, Murphy KR, Pfeiffer RM, George N, Garcia-Closas M, Lissowska J, Brinton LA, Wentzensen N.Am J Epidemiol. 2016 May 1;183(9):800-14.doi: 10.1093/aje/kwv308.

Learn more Learn more
Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women. PMID: 27307466

Chen L, Li CI, Tang MC, Porter P, Hill DA, Wiggins CL, Cook LS.Cancer Epidemiol Biomarkers Prev. 2016 Jun 15.pii: cebp.1104.2015. [Epub ahead of print]

Learn more Learn more
Carcinogenicity of drinking coffee, mate, and very hot beverages. PMID: 27318851

Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.Lancet Oncol. 2016 Jun 14.pii: S1470-2045(16)30239-X. doi: 10.1016/S1470-2045(16)30239-X. [Epub ahead of print]

Learn more Learn more
Diet Quality and Colorectal Cancer Risk in the Women’s Health Initiative Observational Study. PMID: 27267948

Vargas AJ, Neuhouser ML, George SM, Thomson CA, Ho GY, Rohan TE, Kato I, Nassir R, Hou L, Manson JE.Am J Epidemiol. 2016 Jul 1;184(1):23-32. doi: 10.1093/aje/kwv304. Epub 2016 Jun 5.

Learn more Learn more
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. PMID: 27378695

Permuth JB, Pirie A, Chen YA, et al; Ovarian Cancer Association Consortium.Hum Mol Genet. 2016 Jul 4. pii: ddw196. [Epub ahead of print]

Learn more Learn more
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. PMID: 27382091

Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, Robison LL, Sklar CA.J Clin Oncol. 2016 Jul 5. pii: JCO666545. [Epub ahead of print]

Learn more Learn more
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review. PMID: 27541161

Aerts HJ.JAMA Oncol. 2016 Aug 18. doi: 10.1001/jamaoncol.2016.2631. [Epub ahead of print]

Learn more Learn more
Oncocardiology-Past, Present, and Future: A Review. PMID: 27541948

Yeh ET, Chang HM.JAMA Cardiol. 2016 Aug 17. doi: 10.1001/jamacardio.2016.2132. [Epub ahead of print]

Learn more Learn more
Psychological factors associated with the intention to choose for risk- reducing mastectomy in family cancer clinic attendees. PMID: 27639031

van Driel CM, Oosterwijk JC, Meijers-Heijboer EJ, van Asperen CJ, Zeijlmans van Emmichoven IA, de Vries J, Mourits MJ, Henneman L, Timmermans DR, de Bock GH.Breast. 2016 Sep 14;30:66-72.doi: 10.1016/j.breast.2016.08.016. [Epub ahead of print]

Learn more Learn more
Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008. PMID: 27623235

Preston DL, Kitahara CM, Freedman DM, Sigurdson AJ, Simon SL, Little MP, Cahoon EK, Rajaraman P, Miller JS, Alexander BH, Doody MM, Linet MS.Br J Cancer. 2016 Sep 13.doi: 10.1038/bjc.2016.292. [Epub ahead of print]

Learn more Learn more
Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set. PMID: 27743119

Geerse OP, Wynia K, Kruijer M, Schotsman MJ, Hiltermann TJ, Berendsen AJ.Support Care Cancer. 2016 Oct 14.

Learn more Learn more
Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases. PMID: 27701384

Shafrir AL, Babic A, Tamimi RM, Rosner BA, Tworoger SS, Terry KL.Br J Cancer. 2016 Oct 4. doi: 10.1038/bjc.2016.316.

Learn more Learn more
Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. PMID: 27814964

Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G, Mohammed SI, Qiao YL, Rashid SF, Summers D, Sarfati D, Temmerman M, Trimble EL, Padela AI, Aggarwal A, Sullivan R.Lancet. 2016 Nov 1. pii: S0140-6736(16)31393-9.doi: 10.1016/S0140-6736(16)31393-9. [Epub ahead of print] Review.

Learn more Learn more
Cancer treatment and survivorship statistics, 2016. PMID: 27253694

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A.CA Cancer J Clin. 2016 Jul;66(4):271-89.doi: 10.3322/caac.21349.

Learn more Learn more
Physicians’ Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women. PMID: 28029807

Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, McElwain CA, Tergas AI.Cancer Invest. 2016 Dec 28:1-11. doi: 10.1080/07357907.2016.1242597. [Epub ahead of print]

Learn more Learn more
Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer. PMID: 27923781

Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, Eliassen AH, Hunter DJ.Am J Epidemiol. 2016 Dec 15;184(12):884-893.

Learn more Learn more
Maternal exposure to ambient air pollution and risk of early childhood cancers: A population-based study in Ontario, Canada. PMID: 28108116

Lavigne É, Bélair MA, Do MT, Stieb DM, Hystad P, van Donkelaar A, Martin RV, Crouse DL, Crighton E, Chen H, Brook JR, Burnett RT, Weichenthal S, Villeneuve PJ, To T, Cakmak S, Johnson M, Yasseen AS 3rd, Johnson KC, Ofner M, Xie L, Walker M.Environ Int. 2017 Jan 17. pii: S0160-4120(17)30046-6.doi: 10.1016/j.envint.2017.01.004. [Epub ahead of print]

Learn more Learn more
Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer. PMID: 28060958

Fakkert IE, van der Veer E, Abma EM, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, Westrik IG, de Bock GH, Mourits MJ.PLoS One. 2017 Jan 6;12(1):e0169673.doi: 10.1371/journal.pone.0169673.

Learn more Learn more
Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women. PMID: 28202637

Terry PD, Qin B, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Guertin KA, Peters ES, Schwartz AG, Schildkraut JM, Bandera EV.J Nutr. 2017 Feb 15. pii: jn243279.doi: 10.3945/jn.116.243279. [Epub ahead of print]

Learn more Learn more
Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis. PMID: 28204994

Beckwée D, Leysen L, Meuwis K, Adriaenssens N.Support Care Cancer. 2017 Feb 15.doi: 10.1007/s00520-017-3613-z. [Epub ahead of print] Review.

Learn more Learn more
Aromatase expression in atypical ductal hyperplasia in women. PMID: 28337664

Santen RJ, Radisky DC, Degnim A, Frost MH, Vachon CM, Ghosh K, Guestini F, McNamara KM, Sasano H.Breast Cancer Res Treat. 2017 Mar 23.doi: 10.1007/s10549-017-4184-x. [Epub ahead of print]

Learn more Learn more
Health care experiences among women diagnosed with gestational breast cancer. PMID: 28337813

Hammarberg K, Sullivan E, Javid N, Duncombe G, Halliday L, Boyle F, Saunders C, Ives A, Dickinson JE, Fisher J.Eur J Cancer Care (Engl). 2017 Mar 24.doi: 10.1111/ecc.12682. [Epub ahead of print]

Learn more Learn more
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement. PMID: 28389043

Pérez-López FR, Ceausu I, Depypere H, Kehoe S, Lambrinoudaki I, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P, Rees M.Maturitas. 2017 Mar 15. pii: S0378-5122(17)30134-2.doi: 10.1016/j.maturitas.2017.03.003. [Epub ahead of print] Review.

Learn more Learn more
Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis. PMID: 28428185

Maruthappu M, Head MG, Zhou CD, Gilbert BJ, El-Harasis MA, Raine R, Fitchett JR, Atun R.BMJ Open. 2017 Apr 20;7(4):e013936.doi: 10.1136/bmjopen-2016-013936.

Learn more Learn more
Enhanced Recovery After Surgery for Suspected Ovarian Malignancy: A Survey of Perioperative Practice Among Gynecologic Oncologists in Australia and New Zealand to Inform a Clinical Trial. PMID: 28525497

Lindemann K, Kok PS, Stockler M, Sykes P, Brand A.Int J Gynecol Cancer. 2017 Jun;27(5):1046-1050.doi: 10.1097/IGC.0000000000000982.

Learn more Learn more
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. PMID: 28549010

Kuerer HM, Rauch GM, Krishnamurthy S, et al.Ann Surg. 2017 May 25.doi: 10.1097/SLA.0000000000002313. [Epub ahead of print]

Learn more Learn more
Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors. PMID: 28628363

Stolley M, Sheean P, Gerber B, Arroyo C, Schiffer L, Banerjee A, Visotcky A, Fantuzzi G, Strahan D, Matthews L, Dakers R, Carridine-Andrews C, Seligman K, Springfield S, Odoms-Young A, Hong S, Hoskins K, Kaklamani V, Sharp L.J Clin Oncol. 2017 Jun 19:JCO2016719856.doi: 10.1200/JCO.2016.71.9856. [Epub ahead of print]

Learn more Learn more
Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. PMID: 28570827

DeBono NL, Robinson WR, Lund JL, Tse CK, Moorman PG, Olshan AF, Troester MA.J Womens Health (Larchmt). 2017 Jun 1.doi: 10.1089/jwh.2016.6063. [Epub ahead of print]

Learn more Learn more
Patients’ expectations and preferences regarding cancer follow-up care. PMID: 28705438

Brandenbarg D, Berendsen AJ, de Bock GH.Maturitas. 2017 Jul 5.pii: S0378-5122(17)30712-0. doi: 10.1016/j.maturitas.2017.07.001. [Epub ahead of print] Review.

Learn more Learn more
Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer. PMID: 28735467

Griffiths RI, Valderas JM, McFadden EC, Bankhead CR, Lavery BA, Khan NF, Stevens RJ, Keating NL.J Cancer Surviv. 2017 Jul 22.doi: 10.1007/s11764-017-0631-2. [Epub ahead of print]

Learn more Learn more
Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography. PMID: 28822001

Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, Barratt A.Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4443-x. [Epub ahead of print]

Learn more Learn more
Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study. PMID: 28818705

Vermeulen RFM, Beurden MV, Kieffer JM, Bleiker EMA, Valdimarsdottir HB, Massuger LFAG, Mourits MJE, Gaarenstroom KN, van Dorst EBL, van der Putten HWHM, Aaronson NK.Eur J Cancer. 2017 Aug 14;84:159-167. doi: 10.1016/j.ejca.2017.07.018. [Epub ahead of print]

Learn more Learn more
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®): Health Professional Version. PMID: 26389443

PDQ Adult Treatment Editorial Board.PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2017 Sep 13.

Learn more Learn more
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PMID: 28926579

Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, et al.PLoS Med. 2017 Sep 19;14(9):e1002388.doi: 10.1371/journal.pmed.1002388. eCollection 2017 Sep.

Learn more Learn more
Emerging Trends in Family History of Breast Cancer and Associated Risk. PMID: 28986348

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.Cancer Epidemiol Biomarkers Prev. 2017 Oct 6.pii: cebp.0531.2017. doi: 10.1158/1055-9965.EPI-17-0531. [Epub ahead of print]

Learn more Learn more
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13. PMID: 28978555

Davis C, Naci H, Gurpinar E, Poplavska E, Pinto A, Aggarwal A.BMJ. 2017 Oct 4;359:j4530.doi: 10.1136/bmj.j4530.

Learn more Learn more
What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women. PMID: 29138210

Hickey M, Trainer A, Braat S, Davey MA, Krejany E, Wark J.BMJ Open. 2017 Nov 14;7(11):e018758.doi: 10.1136/bmjopen-2017-018758.

Learn more Learn more
ERE-dependent transcription and cell proliferation: Independency of these two processes mediated by the introduction of a sulfone function into the weak estrogen estrothiazine. PMID: 28754571

Jacquot Y, Spaggiari D, Schappler J, Lesniewska E, Rudaz S, Leclercq G.Eur J Pharm Sci. 2017 Nov 15;109:169-181.doi: 10.1016/j.ejps.2017.07.026.

Learn more Learn more
No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study. PMID: 29245077

Lund E, Nakamura A, Thalabard JC.Eur J Cancer. 2017 Dec 12;89:102-112.doi: 10.1016/j.ejca.2017.11.003. [Epub ahead of print]

Learn more Learn more
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. PMID: 29244844

Gschwantler-Kaulich D, Weingartshofer S, Rappaport-Fürhauser C, Zeilinger R, Pils D, Muhr D, Braicu EI, Kastner MT, Tan YY, Semmler L, Sehouli J, Singer CF.PLoS One. 2017 Dec 15;12(12):e0189641.doi: 10.1371/journal.pone.0189641. eCollection 2017.

Learn more Learn more
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years. PMID: 29328860

Lemieux J, Brundage MD, Parulekar WR, Goss PE, Ingle JN, Pritchard KI, Celano P, Muss H, Gralow J, Strasser-Weippl K, Whelan K, Tu D, Whelan TJ.J Clin Oncol. 2018 Jan 12:JCO2017757500.doi: 10.1200/JCO.2017.75.7500. [Epub ahead of print]

Learn more Learn more
Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. PMID: 29338081

Levine JM, Whitton JA, Ginsberg JP, Green DM, Leisenring WM, Stovall M, Robison LL, Armstrong GT, Sklar CA.Cancer. 2018 Jan 16.doi: 10.1002/cncr.31121. [Epub ahead of print]

Learn more Learn more
Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh. PMID: 29420401

Altman D, Rogers RG, Yin L, Tamussino K, Ye W, Iglesia CB.Obstet Gynecol. 2018 Feb 5.doi: 10.1097/AOG.0000000000002496. [Epub ahead of print]

Learn more Learn more
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. PMID: 29404807

Lammert J, Lubinski J, Gronwald J, Huzarski T, Armel S, Eisen A, Meschino WS, Lynch HT, Snyder C, Eng C, Olopade OI, Ginsburg O, Foulkes WD, Elser C, Cohen SA, Kiechle M, Narod SA, Kotsopoulos J.Breast Cancer Res Treat. 2018 Feb 5.doi: 10.1007/s10549-018-4694-1. [Epub ahead of print]

Learn more Learn more
Meat and fiber intake and interaction with pattern recognition receptors (TLR1, TLR2, TLR4, and TLR10) in relation to colorectal cancer in a Danish prospective, case-cohort study. PMID: 29566186

Kopp TI, Vogel U, Tjonneland A, Andersen V.Am J Clin Nutr. 2018 Mar 1;107(3):465-479.doi: 10.1093/ajcn/nqx011.

Learn more Learn more
PDQ Cancer Genetics Editorial Board. Genetics of Breast and Gynecologic PMID: 26389210

Cancers (PDQ®): Health Professional Version. 2018 Mar 12. PDQ Cancer InformationSummaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.

Learn more Learn more
Social inequality in cancer survivors’ health behaviours-A Danish population-based study. PMID: 29668067

Friis K, Larsen FB, Nielsen CV, Momsen AH, Stapelfeldt CM.Eur J Cancer Care (Engl). 2018 Apr 18:e12840.doi: 10.1111/ecc.12840. [Epub ahead of print]

Learn more Learn more
Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer. PMID: 29669187

Shumway DA, Griffith KA, Hawley ST, Wallner LP, Ward KC, Hamilton AS, Morrow M, Katz SJ, Jagsi R.Cancer. 2018 Apr 18.doi: 10.1002/cncr.31378. [Epub ahead of print]

Learn more Learn more
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy. PMID: 29744675

Poggio F, Conte B, Lambertini M.Breast Cancer Res Treat. 2018 May 9. doi: 10.1007/s10549-018-4806-y. [Epub ahead of print] No abstract available.

Learn more Learn more
Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study. PMID: 29750388

Fernandez-Pineda I, Davidoff AM, Lu L, Rao BN, Wilson CL, Srivastava DK, Klosky JL, Metzger ML, Krasin MJ, Ness KK, Pui CH, Robison LL, Hudson MM, Sklar CA, Green DM, Chemaitilly W.Pediatr Blood Cancer. 2018 May 11:e27232. doi: 10.1002/pbc.27232. [Epub ahead of print]

Learn more Learn more
Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis. PMID: 29903800

Pappadis MR, Volk RJ, Krishnan S, Weller SC, Jaramillo E, Hoover DS, Giordano SH, Tan A, Sheffield KM, Housten AJ, Goodwin JS.BMJ Open. 2018 Jun 14;8(6):e022138. doi: 10.1136/bmjopen-2018-022138.

Learn more Learn more
Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial. PMID: 29908297

Kyvernitakis I, Kann PH, Thomasius F, Hars O, Hadji P.Bone. 2018 Jun 13. pii: S8756-3282(18)30239-4. doi: 10.1016/j.bone.2018.06.007. [Epub ahead of print]

Learn more Learn more
Reappraisal of eligibility criteria in cancer clinical trials. PMID: 30020120

Penel N, Lebellec L, Vanseymortier M.Curr Opin Oncol. 2018 Jul 16. doi: 10.1097/CCO.0000000000000470. [Epub ahead of print]

Learn more Learn more
Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands. PMID: 30020493

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.J Natl Cancer Inst. 2018 Jul 18. doi: 10.1093/jnci/djy104. [Epub ahead of print]

Learn more Learn more
Advances in the use of PARP inhibitor therapy for breast cancer. PMID: 30116283

McCann KE, Hurvitz SA.Drugs Context. 2018 Aug 8;7:212540. doi: 10.7573/dic.212540. eCollection 2018. Review.

Learn more Learn more
Histotype classification of ovarian carcinoma: A comparison of approaches. PMID: 30121132

Peres LC, Cushing-Haugen KL, Anglesio M, Wicklund K, Bentley R, Berchuck A, Kelemen LE, Nazeran TM, Gilks CB, Harris HR, Huntsman DG, Schildkraut JM, Rossing MA, Köbel M, Doherty JA.Gynecol Oncol. 2018 Aug 15. pii: S0090-8258(18)31133-8. doi: 10.1016/j.ygyno.2018.08.016. [Epub ahead of print]

Learn more Learn more
US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients. PMID: 30222598

Coroneos CJ, Selber JC, Offodile AC 2nd, Butler CE, Clemens MW.Ann Surg. 2018 Sep 14. doi: 10.1097/SLA.0000000000002990. [Epub ahead of print]

Learn more Learn more
Regular physical activity and mammographic density: a cohort study. PMID: 30194548

Azam S, Kemp Jacobsen K, Aro AR, von Euler-Chelpin M, Tjønneland A, Vejborg I, Lynge E, Andersen ZJ.Cancer Causes Control. 2018 Sep 7. doi: 10.1007/s10552-018-1075-3. [Epub ahead of print]

Learn more Learn more
Classification and Personalized Prognosis in Myeloproliferative Neoplasms. PMID: 30304655

Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, Godfrey AL, Papaemmanuil E, Gundem G, MacLean C, Cook J, O’Neil L, O’Meara S, Teague JW, Butler AP, Massie CE, Williams N, Nice FL, Andersen CL, Hasselbalch HC, Guglielmelli P, McMullin MF, Vannucchi AM, Harrison CN, Gerstung M, Green AR, Campbell PJ.N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.

Learn more Learn more
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3. PMID: 30308388

Cristofanilli M, DeMichele A, Giorgetti C, Turner NC, Slamon DJ, Im SA, Masuda N, Verma S, Loi S, Colleoni M, Theall KP, Huang X, Liu Y, Bartlett CH.Eur J Cancer. 2018 Oct 8;104:21-31. doi: 10.1016/j.ejca.2018.08.011. [Epub ahead of print]

Learn more Learn more
Obesity and Disparities in Human Papillomavirus Vaccination for U.S. Adolescent Girls and Young Women PMID: 30446328

.Harris JA, Garrett AA, Akers AY.Womens Health Issues. 2018 Nov 13. pii: S1049-3867(18)30289-5. doi: 10.1016/j.whi.2018.09.007. [Epub ahead of print]

Learn more Learn more
Socioeconomic Differences in the Epidemiologic Transition From Heart Disease to Cancer as the Leading Cause of Death in the United States, 2003 to 2015: An Observational Study. PMID: 30422275

Hastings KG, Boothroyd DB, Kapphahn K, Hu J, Rehkopf DH, Cullen MR, Palaniappan L.Ann Intern Med. 2018 Nov 13. doi: 10.7326/M17-0796. [Epub ahead of print]

Learn more Learn more
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. PMID: 30554720

Mavaddat N, Michailidou K, Dennis J, et al.Am J Hum Genet. 2018 Dec 5. pii: S0002-9297(18)30405-1. doi: 10.1016/j.ajhg.2018.11.002. [Epub ahead of print]

Learn more Learn more
Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium. PMID: 30561796

Fortner RT, Poole EM, Wentzensen NA, et al.Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32075. [Epub ahead of print]

Learn more Learn more
Persistent vasomotor symptoms and breast cancer in the Women’s Health Initiative. PMID: 30601454

Chlebowski RT, Mortimer JE, Crandall CJ, Pan K, Manson JE, Nelson R, Johnson KC, Vitolin MZ, Lane D, Wactawski-Wende J, Kwan K, Stefanick ML.Menopause. 2018 Dec 28. doi: 10.1097/GME.0000000000001283. [Epub ahead of print]

Learn more Learn more
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. PMID: 30603996

Wunderle M, Pretscher J, Brucker SY, et al.Breast Cancer Res Treat. 2019 Jan 2. doi: 10.1007/s10549-018-05115-6. [Epub ahead of print]

Learn more Learn more
Diet, menopause and the risk of ovarian, endometrial and breast cancer. PMID: 30706844

Dunneram Y, Greenwood DC, Cade JE.Proc Nutr Soc. 2019 Feb 1:1-11. doi: 10.1017/S0029665118002884. [Epub ahead of print]

Learn more Learn more
The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. PMID: 30737679

Kar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, Dörk T, Evans DGR, Gago-Domínguez M, Giles GG, Hartman M, Huo D, Kaaks R, Li J, Lophatananon A, Margolin S, Milne RL, Muir KR, Olsson H, Punie K, Radice P, Simard J, Tamimi RM, Van Nieuwenhuysen E, Wendt C, Zheng W, Pharoah PDP.Eur J Epidemiol. 2019 Feb 8. doi: 10.1007/s10654-019-00485-7. [Epub ahead of print]

Learn more Learn more
Artificial intelligence in breast imaging. PMID: 30898381

Le EPV, Wang Y, Huang Y, Hickman S, Gilbert FJ.Clin Radiol. 2019 Mar 18. pii: S0009-9260(19)30116-3. doi: 10.1016/j.crad.2019.02.006. [Epub ahead of print] Review.

Learn more Learn more
Employment Status and Work Ability in Long-Term Young Adult Cancer Survivors. PMID: 30900929

Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE.J Adolesc Young Adult Oncol. 2019 Mar 22. doi: 10.1089/jayao.2018.0109. [Epub ahead of print]

Learn more Learn more
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study. PMID: 30944092

Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, Cruickshank M.BMJ. 2019 Apr 3;365:l1161. doi: 10.1136/bmj.l1161.

Learn more Learn more
Current Landscape of Immunotherapy in Breast Cancer: A Review. PMID: 30973611

Adams S, Gatti-Mays ME, Kalinsky K, Korde LA, Sharon E, Amiri-Kordestani L, Bear H, McArthur HL, Frank E, Perlmutter J, Page DB, Vincent B, Hayes JF, Gulley JL, Litton JK, Hortobagyi GN, Chia S, Krop I, White J, Sparano J, Disis ML, Mittendorf EA.JAMA Oncol. 2019 Apr 11. doi: 10.1001/jamaoncol.2018.7147. [Epub ahead of print]

Learn more Learn more
Improving Care Coordination to Optimize Health Outcomes in Cancer Survivors. PMID: 31117043

Overholser L, Callaway C.J Natl Compr Canc Netw. 2019 May 1;17(5.5):607-610. doi: 10.6004/jnccn.2019.5009.

Learn more Learn more
HPV-prevalence in elderly women in Denmark. PMID: 31088688

Andersen B, Christensen BS, Christensen J, Ejersbo D, Heje HN, Jochumsen KM, Johansen T, Larsen LG, Lynge E, Serizawa R, Viborg PH, Waldstrøm M.Gynecol Oncol. 2019 May 11. pii: S0090-8258(19)31182-5. doi: 10.1016/j.ygyno.2019.04.680. [Epub ahead of print]

Learn more Learn more
Long term resource consequences of a nationwide introduction of robotic surgery for women with early stage endometrial cancer. PMID: 31176554

Korsholm M, Gyrd-Hansen D, Mogensen O, Möller S, Sopina L, Joergensen SL, Jensen PT.Gynecol Oncol. 2019 Jun 5. pii: S0090-8258(19)31271-5. doi: 10.1016/j.ygyno.2019.05.027. [Epub ahead of print]

Learn more Learn more
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. PMID: 31170563

Rousset-Jablonski C, Selle F, Adda-Herzog E, et al.Eur J Cancer. 2019 Jun 3;116:35-44. doi: 10.1016/j.ejca.2019.04.018. [Epub ahead of print]

Learn more Learn more
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis. PMID: 31319173

Brotherton JM, Budd A, Rompotis C, Bartlett N, Malloy MJ, Andersen RL, Coulter KA, Couvee PW, Steel N, Ward GH, Saville M.Papillomavirus Res. 2019 Jul 15:100177. doi: 10.1016/j.pvr.2019.100177. [Epub ahead of print]

Learn more Learn more
Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types. PMID: 31319386

Kamath SD, Kircher SM, Benson AB.J Natl Compr Canc Netw. 2019 Jul 1;17(7):849-854. doi: 10.6004/jnccn.2018.7280.

Learn more Learn more
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis. PMID: 31319173

Brotherton JM, Budd A, Rompotis C, Bartlett N, Malloy MJ, Andersen RL, Coulter KA, Couvee PW, Steel N, Ward GH, Saville M.Papillomavirus Res. 2019 Jul 15:100177. doi: 10.1016/j.pvr.2019.100177. [Epub ahead of print]

Learn more Learn more
Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types. PMID: 31319386

Kamath SD, Kircher SM, Benson AB.J Natl Compr Canc Netw. 2019 Jul 1;17(7):849-854. doi: 10.6004/jnccn.2018.7280.

Learn more Learn more
Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database. PMID: 31541655

Lee CS, Ashih H, Sengupta D, Sickles EA, Zuley M, Pisano E.J Am Coll Radiol. 2019 Sep 18. pii: S1546-1440(19)31034-8. doi: 10.1016/j.jacr.2019.08.033. [Epub ahead of print]

Learn more Learn more
Ovarian tissue cryopreservation: low usage rates and high life birth rate after transplantation. PMID: 31538662

Hoekman EJ, Louwe LA, Rooijers M, van der Westerlaken LAJ, Klijn NF, Pilgram GSK, de Kroon CD, Hilders CGJM.Acta Obstet Gynecol Scand. 2019 Sep 20. doi: 10.1111/aogs.13735. [Epub ahead of print]

Learn more Learn more
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. PMID: 31589872

Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA.Gastroenterology. 2019 Oct 4. pii: S0016-5085(19)41411-X. doi: 10.1053/j.gastro.2019.09.039. [Epub ahead of print]

Learn more Learn more
Selective progesterone receptor modulators in early stage breast cancer: a randomized, placebo-controlled Phase II window of opportunity trial using telapristone acetate. PMID: 31570566

Lee O, Sullivan ME, Xu Y, Rodgers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA.Clin Cancer Res. 2019 Sep 30. pii: clincanres.0443.2019. doi: 10.1158/1078-0432.CCR-19-0443. [Epub ahead of print]

Learn more Learn more
Decision-Making in Gynaecological Oncology Multidisciplinary Team Meetings: A Cross-Sectional, Observational Study of Ovarian Cancer Cases. PMID: 31743932

Scott R, Hawarden A, Russell B, Edmondson RJ.Oncol Res Treat. 2019 Nov 19:1-6. doi: 10.1159/000504260. [Epub ahead of print]

Learn more Learn more
Hormonal and reproductive factors and reduction in the risk of colorectal cancer. PMID: 31714342

Rennert G, Rennert HS, Pinchev M, Gruber SB, Lavie O.Eur J Cancer Prev. 2019 Nov 7. doi: 10.1097/CEJ.0000000000000538. [Epub ahead of print]

Learn more Learn more
Premenopausal gynecologic surgery and survival among black and white women with breast cancer. PMID: 31828465

Roberson ML, Nichols HB, Olshan AF, A Troester M, Robinson WR.Cancer Causes Control. 2019 Dec 11. doi: 10.1007/s10552-019-01255-2. [Epub ahead of print]

Learn more Learn more
Sustained weight loss and risk of breast cancer in women ≥50 years: a pooled analysis of prospective data. PMID: 31845728

Teras LR, Patel AV, Wang M, Yaun SS, Anderson K, Brathwaite R, Caan BJ, Chen Y, Connor AE, Eliassen AH, Gapstur SM, Gaudet MM, Genkinger JM, Giles GG, Lee IM, Milne RL, Robien K, Sawada N, Sesso HD, Stampfer MJ, Tamimi RM, Thomson CA, Tsugane S, Visvanathan K, Willett WC, Zeleniuch-Jacquotte A, Smith-Warner SA.J Natl Cancer Inst. 2019 Dec 13. pii: djz226. doi: 10.1093/jnci/djz226. [Epub ahead of print]

Learn more Learn more
Improved early detection of ovarian cancer using longitudinal multimarker models. PMID: 31937926

Whitwell HJ, Worthington J, Blyuss O, Gentry-Maharaj A, Ryan A, Gunu R, Kalsi J, Menon U, Jacobs I, Zaikin A, Timms JF.Br J Cancer. 2020 Jan 15. doi: 10.1038/s41416-019-0718-9. [Epub ahead of print]

Learn more Learn more
Neurocognitive and psychosocial outcomes in adult survivors of childhood soft-tissue sarcoma: A report from the St. Jude Lifetime Cohort. PMID: 31913509

Tonning Olsson I, Brinkman TM, Wang M, Ehrhardt MJ, Banerjee P, Mulrooney DA, Huang IC, Ness KK, Bishop MW, Srivastava D, Robison LL, Hudson MM, Krull KR.Cancer. 2020 Jan 8. doi: 10.1002/cncr.32694. [Epub ahead of print]

Learn more Learn more
Alcohol and tobacco use in relation to mammographic density in 23,456 women. PMID: 32066618

McBride RB, Fei K, Rothstein JH, Alexeeff SE, Song X, Sakoda LC, McGuire V, Achacoso N, Acton L, Liang RY, Lipson JA, Yaffe MJ, Rubin DL, Whittemore AS, Habel LA, Sieh W.Cancer Epidemiol Biomarkers Prev. 2020 Feb 17. pii: cebp.0348.2019. doi: 10.1158/1055-9965.EPI-19-0348. [Epub ahead of print]

Learn more Learn more
Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and race/ethnicity: The Breast Cancer Etiology in Minorities (BEM) Study. PMID: 32064598

John EM, Phipps AI, Hines LM, Koo J, Ingles SA, Baumgartner KB, Slattery ML, Wu AH.Int J Cancer. 2020 Feb 16. doi: 10.1002/ijc.32923. [Epub ahead of print]

Learn more Learn more
Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. PMID: 26389210

PDQ Cancer Genetics Editorial Board.PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2020 Mar 6.

Learn more Learn more
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival. PMID: 32188726

Melief CJM, Welters MJP, Vergote I, Kroep JR, Kenter GG, Ottevanger PB, Tjalma WAA, Denys H, van Poelgeest MIE, Nijman HW, Reyners AKL, Velu T, Goffin F, Lalisang RI, Loof NM, Boekestijn S, Krebber WJ, Hooftman L, Visscher S, Blumenstein BA, Stead RB, Gerritsen W, van der Burg SH.Sci Transl Med. 2020 Mar 18;12(535). pii: eaaz8235. doi: 10.1126/scitranslmed.aaz8235.

Learn more Learn more
Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. PMID: 26389210

PDQ Cancer Genetics Editorial Board.PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2020 Mar 6.

Learn more Learn more
Dioxin exposure and breast cancer risk in a prospective cohort study. PMID: 32305677

VoPham T, Bertrand KA, Jones RR, Deziel NC, DuPré NC, James P, Liu Y, Vieira VM, Tamimi RM, Hart JE, Ward MH, Laden F.Environ Res. 2020 Apr 13;186:109516. doi: 10.1016/j.envres.2020.109516. Online ahead of print.

Learn more Learn more
The evolving epidemic of breast cancer in sub-Saharan Africa. Results from the African Cancer Registry Network. PMID: 32306390

Joko-Fru WY, Jedy-Agba E, Korir A, Ogunbiyi O, Dzamalala CP, Chokunonga E, Wabinga H, Manraj S, Finesse A, Somdyala N, Liu B, McGale P, Jemal A, Bray F, Parkin DM.Int J Cancer. 2020 Apr 19. doi: 10.1002/ijc.33014. Online ahead of print.

Learn more Learn more
Scaling up the surveillance of childhood cancer: a global roadmap. PMID: 32433739

Piñeros M, Mery L, Soerjomataram I, Bray F, Steliarova-Foucher E.J Natl Cancer Inst. 2020 May 20:djaa069. doi: 10.1093/jnci/djaa069. Online ahead of print.

Learn more Learn more
Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: an individual participant data meta-analysis. PMID: 32433797

Takada T, van Doorn S, Parpia S, de Wit K, Anderson DR, Stevens SM, Woller SC, Ten Cate-Hoek AJ, Elf JL, Kraaijenhagen RA, Schutgens REG, Wells PS, Kearon C, Moons KGM, Geersing GJ.J Thromb Haemost. 2020 May 20. doi: 10.1111/jth.14900. Online ahead of print.

Learn more Learn more
Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act. PMID: 32534810

Sutaria T, Sparks AD, Rao YJ, Lopez-Acevedo M, Long B.Gynecol Oncol. 2020 Jun 11:S0090-8258(20)31096-9. doi: 10.1016/j.ygyno.2020.05.027. Online ahead of print.

Learn more Learn more
Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE). PMID: 32554541

Talhouk A, George J, Wang C, et al .Clin Cancer Res. 2020 Jun 17:clincanres.0103.2020. doi: 10.1158/1078-0432.CCR-20-0103. Online ahead of print.

Learn more Learn more
Identifying oncogenic drivers associated with increased risk of late distant recurrence in post-menopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study. PMID: 32652112

Luen SJ, Asher R, Lee CK, Savas P, Kammler R, Dell’Orto P, Biasi M, Demanse D, Hackl W, Thuerlimann B, Viale G, Di Leo A, Colleoni M, Regan MM, Loi S.Ann Oncol. 2020 Jul 8:S0923-7534(20)39934-8. doi: 10.1016/j.annonc.2020.06.024. Online ahead of print.

Learn more Learn more
Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women. PMID: 32661909

Conlan MG, de Vries EFJ, Glaudemans A, Wang Y, Troy S.Eur J Drug Metab Pharmacokinet. 2020 Jul 13. doi: 10.1007/s13318-020-00635-3. Online ahead of print.

Learn more Learn more
The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts. PMID: 32816894

Broom A, Kenny K, Page A, Cort N, Lipp E, Tan AC, Ashley DM, Walsh KM, Khasraw M.Clin Cancer Res. 2020 Aug 18:clincanres.2989.2020. doi: 10.1158/1078-0432.CCR-20-2989. Online ahead of print.

Learn more Learn more
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial (Vaidya) PMID: 32816842

 JS, Bulsara M, Baum M, Wenz F, Massarut S, et al.BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836.

Learn more Learn more
Organoid models in gynaecological oncology research. PMID: 32932156

Semertzidou A, Brosens JJ, McNeish I, Kyrgiou M.Cancer Treat Rev. 2020 Sep 1;90:102103. doi: 10.1016/j.ctrv.2020.102103. Online ahead of print.

Learn more Learn more
Total and added sugar intakes, sugar types, and cancer risk: results from the prospective NutriNet-Santé cohort. PMID: 32936868

Debras C, Chazelas E, Srour B, Kesse-Guyot E, Julia C, Zelek L, Agaësse C, Druesne-Pecollo N, Galan P, Hercberg S, Latino-Martel P, Deschasaux M, Touvier M.Am J Clin Nutr. 2020 Sep 16:nqaa246. doi: 10.1093/ajcn/nqaa246. Online ahead of print.

Learn more Learn more
Prospective Cohort Study of Pre- and Postdiagnosis Physical Activity and Endometrial Cancer Survival. PMID: 33026939

Friedenreich CM, Cook LS, Wang Q, Kokts-Porietis RL, McNeil J, Ryder-Burbidge C, Courneya KS.J Clin Oncol. 2020 Oct 7:JCO2001336. doi: 10.1200/JCO.20.01336. Online ahead of print.

Learn more Learn more
Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. PMID: 33038275

Christakoudi S, Pagoni P, Ferrari P, et al.Int J Cancer. 2020 Oct 10. doi: 10.1002/ijc.33339. Online ahead of print.

Learn more Learn more
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of arandomised, phase 3 trial. PMID: 33152277

Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.Lancet Oncol. 2020 Nov 2:S1470-2045(20)30472-1. doi: 10.1016/S1470-2045(20)30472-1. Online ahead of print.

Learn more Learn more
50th ANNIVERSARY OF THE FIRST CLINICAL TRIAL WITH ICI 46,474 (TAMOXIFEN): THEN WHAT HAPPENED? PMID: 33151906

Jordan VC.Endocr Relat Cancer. 2020 Nov 1:ERC-20-0335. doi: 10.1530/ERC-20-0335. Online ahead of print.

Learn more Learn more
Age and racial differences in the presentation of gestational trophoblastic neoplasia. PMID: 33310882

Diver E, Richardson M, Liao CI, Mann AK, Darcy KM, Tian C, Kapp DS, Chan JK.Int J Gynecol Cancer. 2020 Dec 12:ijgc-2020-002105. doi: 10.1136/ijgc-2020-002105. Online ahead of print.

Learn more Learn more
Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up. PMID: 33326342

Kjaer SK, Nygård M, Sundström K, Munk C, Berger S, Dzabic M, Fridrich KE, Waldstrøm M, Sørbye SW, Bautista O, Group T, Luxembourg A.Hum Vaccin Immunother. 2020 Dec 16:1-7. doi: 10.1080/21645515.2020.1839292. Online ahead of print.

Learn more Learn more
Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies. PMID: 33433939

O’Brien KM, Tworoger SS, Harris HR, Trabert B, Weinberg CR, Fortner RT, D’Aloisio AA, Kaunitz AM, Wentzensen N, Sandler DP.Int J Cancer. 2021 Jan 12. doi: 10.1002/ijc.33470. Online ahead of print.

Learn more Learn more
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. PMID: 33397713

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O’Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL.Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.

Learn more Learn more
Circulating biomarkers of inflammation and ovarian cancer risk in the Nurses’ Health Studies. PMID: 33563649

Peres LC, Townsend MK, Birmann BM, Conejo-Garcia JR, Kim Y, Kubzansky LD, Magpantay LI, Martínez-Maza O, Tworoger SS.Cancer Epidemiol Biomarkers Prev. 2021 Feb 9:cebp.1390.2020.doi: 10.1158/1055-9965.EPI-20-1390. Online ahead of print.

Learn more Learn more
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors. PMID: 33575860

Peate M, Saunders C, Cohen P, Hickey M.Breast Cancer Res Treat. 2021 Feb 11.doi: 10.1007/s10549-021-06117-7. Online ahead of print.

Learn more Learn more
Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study. PMID: 33865453

Fornili M, Perduca V, Fournier A, Jérolon A, Boutron-Ruault MC, Maskarinec G, Severi G, Baglietto L.Breast Cancer Res. 2021 Apr 17;23(1):47. doi: 10.1186/s13058-021-01425-8.

Learn more Learn more
Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study. PMID: 33857339

Liu Q, Simin J, Debelius J, Fall K, Sadr-Azodi O, Engstrand L, Williams C, Brusselaers N.Aliment Pharmacol Ther. 2021 Apr 15. doi: 10.1111/apt.16362. Online ahead of print.

Learn more Learn more
Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database. PMID: 33962993

Nasioudis D, Byrne M, Ko EM, Haggerty AF, Cory L, Giuntoli Ii RL, Kim SH, Latif NA.Int J Gynecol Cancer. 2021 May 6:ijgc-2021-002543. doi: 10.1136/ijgc-2021-002543. Online ahead of print.

Learn more Learn more
What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. PMID: 33972087

Hickey M, Moss KM, Mishra GD, Krejany EO, Domchek SM, Wark JD, Trainer A, Wild RA.Gynecol Oncol. 2021 May 7:S0090-8258(21)00358-9. doi: 10.1016/j.ygyno.2021.04.038. Online ahead of print.

Learn more Learn more
Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database. PMID: 33962993

Nasioudis D, Byrne M, Ko EM, Haggerty AF, Cory L, Giuntoli Ii RL, Kim SH, Latif NA.Int J Gynecol Cancer. 2021 May 6:ijgc-2021-002543. doi: 10.1136/ijgc-2021-002543. Online ahead of print.

Learn more Learn more
What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. PMID: 33972087

Hickey M, Moss KM, Mishra GD, Krejany EO, Domchek SM, Wark JD, Trainer A, Wild RA.Gynecol Oncol. 2021 May 7:S0090-8258(21)00358-9. doi: 10.1016/j.ygyno.2021.04.038. Online ahead of print.

Learn more Learn more
Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women’s Health Initiative. PMID: 34136908

Peila R, Chlebowski RT, Ballinger TJ, Kamensky V, Richey PA, Saquib N, Shadyab AH, Wassertheil-Smoller S, Rohan TE.Int J Epidemiol. 2021 Jun 17:dyab113. doi: 10.1093/ije/dyab113. Online ahead of print.

Learn more Learn more
Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. PMID: 34148186

Castro-Espin C, Agudo A, Bonet C, Katzke V, Turzanski-Fortner R, Aleksandrova K, Schulze MB, Tjønneland A, Dahm CC, Quirós JR, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Masala G, Sieri S, Tumino R, Sacerdote C, Panico S, May AM, Bodén S, Gram IT, Skeie G, Laouali N, Shah S, Severi G, Aune D, Merritt MA, Cairat M, Weiderpass E, Riboli E, Dossus L, Jakszyn P.Eur J Epidemiol. 2021 Jun 20. doi: 10.1007/s10654-021-00772-2. Online ahead of print.

Learn more Learn more
Uterine serous carcinoma: key advances and novel treatment approaches. PMID: 34210768

Ferriss JS, Erickson BK, Shih IM, Fader AN.Int J Gynecol Cancer. 2021 Jul 1:ijgc-2021-002753. doi: 10.1136/ijgc-2021-002753. Online ahead of print.

Learn more Learn more
Prolactin and Risk of Epithelial Ovarian Cancer. PMID: 34244157

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.Cancer Epidemiol Biomarkers Prev. 2021 Jul 8:cebp.0139.2021. doi: 10.1158/1055-9965.EPI-21-0139. Online ahead of print.

Learn more Learn more
Uterine serous carcinoma: key advances and novel treatment approaches. PMID: 34210768

Ferriss JS, Erickson BK, Shih IM, Fader AN.Int J Gynecol Cancer. 2021 Jul 1:ijgc-2021-002753. doi: 10.1136/ijgc-2021-002753. Online ahead of print.

Learn more Learn more
Prolactin and Risk of Epithelial Ovarian Cancer. PMID: 34244157

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.Cancer Epidemiol Biomarkers Prev. 2021 Jul 8:cebp.0139.2021. doi: 10.1158/1055-9965.EPI-21-0139. Online ahead of print.

Learn more Learn more
Uterine serous carcinoma: key advances and novel treatment approaches. PMID: 34210768

Ferriss JS, Erickson BK, Shih IM, Fader AN.Int J Gynecol Cancer. 2021 Jul 1:ijgc-2021-002753. doi: 10.1136/ijgc-2021-002753. Online ahead of print.

Learn more Learn more
Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic. PMID: 34390418

Doukas PG, Patel RN, Venkatesh V, Khan SS, Baldridge A, Akhter N.Breast Cancer Res Treat. 2021 Aug 14. doi: 10.1007/s10549-021-06353-x. Online ahead of print.

Learn more Learn more
Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women’s circle of Health Study. PMID: 34390715

Rao R, McDonald JA, Barrett ES, Greenberg P, Teteh DK, Montgomery SB, Qin B, Lin Y, Hong CC, Ambrosone CB, Demissie K, Bandera EV, Llanos AAM.Environ Res. 2021 Aug 11:111863. doi: 10.1016/j.envres.2021.111863. Online ahead of print.

Learn more Learn more
In-hospital mortality, length of stay, and hospital costs for hospitalized breast cancer patients with comorbid-heart failure in the USA. PMID: 34525896

Park C, Park SK, Upshaw JN, Schonberg MA.Curr Med Res Opin. 2021 Sep 16:1. doi: 10.1080/03007995.2021.1980775. Online ahead of print.

Learn more Learn more
Cost-effectiveness of prophylactic hysterectomy in first-degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study. PMID: 34510779

Alblas M, Peterse EFP, Du M, Zauber AG, Steyerberg EW, van Leeuwen N, Lansdorp-Vogelaar I.Cancer Med. 2021 Sep 12. doi: 10.1002/cam4.4080. Online ahead of print.

Learn more Learn more
Lynch syndrome screening of women with endometrial cancer: feasibility and outcomes in a community program. PMID: 34656766

Turashvili G, McLachlin CM, Lin H, Gharbharan R, Colgan T.J Obstet Gynaecol Can. 2021 Oct 14:S1701-2163(21)00753-2. doi: 10.1016/j.jogc.2021.08.014. Online ahead of print.

Learn more Learn more
Diet quality and all-cause and cancer-specific mortality in cancer survivors and non-cancer individuals: the Multiethnic Cohort Study. PMID: 34657186

Park SY, Kang M, Shvetsov YB, Setiawan VW, Boushey CJ, Haiman CA, Wilkens LR, Le Marchand L.Eur J Nutr. 2021 17 October. doi: 10.1007/s00394-021-02700-2. Online ahead of print.

Learn more Learn more
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. PMID: 34775483

Récher C, Röllig C, Bérard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhäuser M, Platzbecker U, Müller-Tidow C, Baldus CD, Martínez-Cuadrón D, Serrano J, Martínez-Sánchez P, Arbolí ER, Gil C, Bergua J, Bernal T, de la Fuente Burguera A, Delabesse E, Bidet A, Pigneux A, Montesinos P.Leukemia. 2021 Nov 13. doi: 10.1038/s41375-021-01425-9. Online ahead of print.

Learn more Learn more
Risk of de novo cancer after premenopausal bilateral oophorectomy. PMID: 34774521

Huo N, Smith CY, Gazzuola Rocca L, Rocca WA, Mielke MM.Am J Obstet Gynecol. 2021 Nov 10:S0002-9378(21)01222-9. doi: 10.1016/j.ajog.2021.10.040. Online ahead of print.

Learn more Learn more
Oral contraceptive and menopausal hormone therapy use and risk of pituitary adenoma: cohort and case-control analyses. PMID: 34865056

Cote DJ, Kilgallon JL, Nawabi NLA, Dawood HY, Smith TR, Kaiser UB, Laws ER, Manson JAE, Stampfer MJ.J Clin Endocrinol Metab. 2021 Dec 3:dgab868. doi: 10.1210/clinem/dgab868. Online ahead of print.

Learn more Learn more
Dietary and Supplemental Vitamin C Intake and Risk of Breast Cancer: Results from the Nurses’ Health Studies. PMID: 34865068

Cadeau C, Farvid MS, Rosner BA, Willett WC, Eliassen AH.J Nutr. 2021 Dec 3:nxab407. doi: 10.1093/jn/nxab407. Online ahead of print.

Learn more Learn more
Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center. PMID: 35040284

Tatineni S, Tarockoff M, Abdallah N, Purrington KS, Assad H, Reagle R, Petrucelli N, Simon MS.Cancer Med. 2022 Jan 17. doi: 10.1002/cam4.4541. Online ahead of print.

Learn more Learn more
Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. PMID: 34999853

Ellingjord-Dale M, Christakoudi S, Weiderpass E, Panico S, Dossus L, Olsen A, Tjønneland A, Kaaks R, Schulze MB, Masala G, Gram IT, Skeie G, Rosendahl AH, Sund M, Key T, Ferrari P, Gunter M, Heath AK, Tsilidis KK, Riboli E; additional authors.Int J Epidemiol. 2022 Jan 6;50(6):1914-1926. doi: 10.1093/ije/dyab032.

Learn more Learn more
Long-Term Follow-Up of Fractional CO(2) Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors. PMID: 35160226

Quick AM, Hundley A, Evans C, Stephens JA, Ramaswamy B, Reinbolt RE, Noonan AM, Van Deusen JB, Wesolowski R, Stover DG, Williams NO, Sardesai SD, Faubion SS, Loprinzi CL, Lustberg MB.J Clin Med. 2022 Jan 31;11(3):774. doi: 10.3390/jcm11030774.

Learn more Learn more
Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists. PMID: 35174864

Mai JZ, Zhang R, Sargen MR, Little MP, Alexander BH, Tucker MA, Kitahara CM, Cahoon EK.Hum Reprod. 2022 Feb 17:deac029. doi: 10.1093/humrep/deac029. Online ahead of print.

Learn more Learn more
Updates in the treatment of vaginal cancer. PMID: 35256422

Jhingran A.Int J Gynecol Cancer. 2022 Mar;32(3):344-351. doi: 10.1136/ijgc-2021-002517.

Learn more Learn more
Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. PMID: 35285003

Nosé V, Gill A, Teijeiro JMC, Perren A, Erickson L.Endocr Pathol. 2022 Mar 13. doi: 10.1007/s12022-022-09705-5. Online ahead of print.

Learn more Learn more
The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020. PMID: 35419824

Johansson AL, Larønningen S, Skovlund CW, Kristiansen MF, Mørch LS, Friis S, Johannesen TB, Myklebust TÅ, Skog A, Pettersson D, Birgisson H, Virtanen A, Malila N, Pitkäniemi J, Tanskanen T, Tryggvadóttir L, Ursin G, Lambe M.Int J Cancer. 2022 Apr 13. doi: 10.1002/ijc.34029. Online ahead of print.

Learn more Learn more
Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: Results from the CARE Registry. PMID: 35403211

Williams GR, Al-Obaidi M, Harmon C, Dai C, Outlaw D, Gbolahan O, Khushman M, Nyrop KA, Gilmore N, Bhatia S, Giri S.Cancer. 2022 Apr 11. doi: 10.1002/cncr.34178. Online ahead of print.

Learn more Learn more
Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. PMID: 35501391

Greene G, Griffiths R, Han J, Akbari A, Jones M, Lyons J, Lyons RA, Rolles M, Torabi F, Warlow J, Morris ERA, Lawler M, Huws DW.Br J Cancer. 2022 May 2. doi: 10.1038/s41416-022-01830-6. Online ahead of print.

Learn more Learn more
Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgery. PMID: 35501570

Kohut A, Whitaker T, Walter L, Li SY, Han E, Lee S, Wakabayashi MT, Dellinger TH, Han ES, Rodriguez-Rodriguez L, Chung C.Int Urogynecol J. 2022 May 2. doi: 10.1007/s00192-022-05212-7. Online ahead of print.

Learn more Learn more
Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database. PMID: 35690079

Grimm LJ, Lee C, Rosenberg RD, Burleson J, Simanowith M, Fruscello T Jr, Pelzl CE, Friedewald SM, Moy L, Zuley ML.J Am Coll Radiol. 2022 Jun 2:S1546-1440(22)00347-7. doi: 10.1016/j.jacr.2022.04.008. Online ahead of print.

Learn more Learn more
Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer. PMID: 35691755

Heald B, Mokhtary S, Nielsen SM, Rojahn S, Yang S, Michalski ST, Esplin ED.Gynecol Oncol. 2022 Jun 9:S0090-8258(22)00334-1. doi: 10.1016/j.ygyno.2022.05.023. Online ahead of print.

Learn more Learn more
Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database. PMID: 35690079

Grimm LJ, Lee C, Rosenberg RD, Burleson J, Simanowith M, Fruscello T Jr, Pelzl CE, Friedewald SM, Moy L, Zuley ML.J Am Coll Radiol. 2022 Jun 2:S1546-1440(22)00347-7. doi: 10.1016/j.jacr.2022.04.008. Online ahead of print.

Learn more Learn more
Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer. PMID: 35691755

Heald B, Mokhtary S, Nielsen SM, Rojahn S, Yang S, Michalski ST, Esplin ED.Gynecol Oncol. 2022 Jun 9:S0090-8258(22)00334-1. doi: 10.1016/j.ygyno.2022.05.023. Online ahead of print.

Learn more Learn more
Outcomes of gynecological cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-GO Cancer study. PMID: 35779589

Fotopoulou C, Khan T, Bracinik J, Glasbey J, Abu-Rustum N, Chiva L, Fagotti A, Fujiwara K, Ghebre R, Gutelkin M, Konney TO, Ng J, Pareja R, Seenivasagam RK, Sehouli J, Surappa S, Bhangu A, Leung E, Sundar S; CovidSurg Gynecological cancer collaborators.Am J Obstet Gynecol. 2022 Jun 29:S0002-9378(22)00528-2. doi: 10.1016/j.ajog.2022.06.052. Online ahead of print.

Learn more Learn more
Improving health-related quality of life in women with breast, blood, and gynaecological Cancer with an eHealth-enabled 12-week lifestyle intervention: the women’s wellness after Cancer program randomised controlled trial. PMID: 35804322

Seib C, Anderson D, McGuire A, Porter-Steele J, McDonald N, Balaam S, Sapkota D, McCarthy AL.BMC Cancer. 2022 Jul 8;22(1):747. doi: 10.1186/s12885-022-09797-6.

Learn more Learn more
Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma. PMID: 35882426

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA.Int J Gynecol Cancer. 2022 Jul 26:ijgc-2022-003450. doi: 10.1136/ijgc-2022-003450. Online ahead of print.

Learn more Learn more
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. PMID: 35965239

Markowitz LE, Drolet M, Lewis RM, Lemieux-Mellouki P, Pérez N, Jit M, Brotherton JM, Ogilvie G, Kreimer AR, Brisson M.Vaccine. 2022 Aug 11:S0264-410X(22)00834-9. doi: 10.1016/j.vaccine.2022.06.065. Online ahead of print.

Learn more Learn more
Effects of risk factors for ovarian cancer in women with and without endometriosis. PMID: 36182623

Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, Kjaer SK, Anton-Culver H, Ziogas A, Berchuck A, Khoja L, Wu AH, Pike MC, Pearce CL, Lee AW.Fertil Steril. 2022 Sep 28:S0015-0282(22)00475-7. doi: 10.1016/j.fertnstert.2022.07.019. Online ahead of print.

Learn more Learn more
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. PMID: 36184683

Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N.Nat Commun. 2022 Oct 2;13(1):5797. doi: 10.1038/s41467-022-33598-x.

Learn more Learn more
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening. PMID: 36383381

Joung RH, Mullett TW, Kurtzman SH, Shafir S, Harris JB, Yao KA, Bilimoria KY, Cance WG, Nelson H; Return-to-Screening Quality Improvement Collaborative.JAMA Netw Open. 2022 Nov 1;5(11):e2242354. doi: 10.1001/jamanetworkopen.2022.42354.

Learn more Learn more
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial. PMID: 36383926

Bartels SAL, Donker M, Poncet C, Sauvé N, Straver ME, van de Velde CJH, Mansel RE, Blanken C, Orzalesi L, Klinkenbijl JHG, van der Mijle HCJ, Nieuwenhuijzen GAP, Veltkamp SC, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JWS, Belkacemi Y, Petignat P, Schinagl DAX, Coens C, van Tienhoven G, van Duijnhoven F, Rutgers EJT.J Clin Oncol. 2022 Nov 16:JCO2201565. doi: 10.1200/JCO.22.01565. Online ahead of print.

Learn more Learn more
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. PMID: 36623243

Yadav S, Boddicker NJ, Na J, Polley EC, Hu C, Hart SN, Gnanaolivu RD, Larson N, Holtegaard S, Huang H, Dunn CA, Teras LR, Patel AV, Lacey JV, Neuhausen SL, Martinez E, Haiman C, Chen F, Ruddy KJ, Olson JE, John EM, Kurian AW, Sandler DP, O'Brien KM, Taylor JA, Weinberg CR, Anton-Culver H, Ziogas A, Zirpoli G, Goldgar DE, Palmer JR, Domchek SM, Weitzel JN, Nathanson KL, Kraft P, Couch FJ.
J Clin Oncol. 2023 Jan 9:JCO2201239. doi: 10.1200/JCO.22.01239. Online ahead of print.

Learn more Learn more
Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. PMID: 36639731

Asangba AE, Chen J, Goergen KM, Larson MC, Oberg AL, Casarin J, Multinu F, Kaufmann SH, Mariani A, Chia N, Walther-Antonio MRS.
Sci Rep. 2023 Jan 13;13(1):730. doi: 10.1038/s41598-023-27555-x.

Learn more Learn more
Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population. PMID: 36751052

Radu CA, Matos de Melo Fernandes N, Khalfe S, Stordal B.
Cancer Med. 2023 Feb 7. doi: 10.1002/cam4.5670. Online ahead of print.

Learn more Learn more
Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma. PMID: 36773710

Nagao Y, Yokoi A, Yoshida K, Sugiyama M, Watanabe E, Nakamura K, Kitagawa M, Asano-Inami E, Koya Y, Yoshihara M, Tamauchi S, Shimizu Y, Ikeda Y, Yoshikawa N, Kato T, Yamamoto Y, Kajiyama H.
Pharmacol Res. 2023 Feb 9:106693. doi: 10.1016/j.phrs.2023.106693. Online ahead of print.

Learn more Learn more
Biomarker-driven therapy in endometrial cancer. PMID: 36878569

Karpel H, Slomovitz B, Coleman RL, Pothuri B.
Int J Gynecol Cancer. 2023 Mar 6;33(3):343-350. doi: 10.1136/ijgc-2022-003676.

Learn more Learn more
The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01). PMID: 36872873

Neuman HB, Schumacher JR, Edge SB, Ruddy KJ, Partridge AH, Yu M, Vanness DJ, Hanlon BM, Le-Rademacher JG, Yang DY, Havlena J, Strand CA, Greenberg CC.
Cancer. 2023 Mar 6. doi: 10.1002/cncr.34656. Online ahead of print.

 

Learn more Learn more
Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). PMID: 37029916

Harvey SV, Wentzensen N, Bertrand K, Black A, Brinton LA, Chen C, Costas L, Dal Maso L, De Vivo I, Du M, Garcia-Closas M, Goodman MT, Gorzelitz J, Johnson L, Lacey JV, Liao L, Lipworth L, Lissowska J, Miller AB, O'Connell K, O'Mara TA, Ou X, Palmer JR, Patel AV, Paytubi S, Pelegrina B, Petruzella S, Prizment A, Rohan T, Sandin S, Setiawan VW, Sinha R, Trabert B, Webb PM, Wilkens LR, Xu W, Yang HP, Zheng W, Clarke MA.
Int J Epidemiol. 2023 Apr 8:dyad046. doi: 10.1093/ije/dyad046. Online ahead of print.

 

Learn more Learn more
Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes. PMID: 37030072

Schwartz ZP, Li AJ, Walsh CS, Rimel BJ, Alvarado MM, Lentz SE, Cass I.
Gynecol Oncol. 2023 Apr 6;173:1-7. doi: 10.1016/j.ygyno.2023.03.017. Online ahead of print.

Learn more Learn more
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. PMID: 37132126

Nebgen DR, Domchek SM, Kotsopoulos J, de Hullu JA, Crosbie EJ, Paramanandam VS, van Zanten MB, Norquist BM, Guise T, Rozenberg S, Kurian AW, Pederson HJ, Yuksel N, Michaelson-Cohen R, Bober SL, da Silva Filho AL, Johansen N, Guidozzi F, Evans DG, Menon U, Kingsberg SA, Powell CB, Grandi G, Marchetti C, Jacobson M, Brennan DJ, Hickey M.

BJOG. 2023 May 2. doi: 10.1111/1471-0528.17511. Online ahead of print.

 

Learn more Learn more
Safety of fertility sparing management in invasive mucinous ovarian carcinoma. PMID: 37182433

Kim SR, Madariaga A, Hogen L, Vicus D, Covens A, Parra-Herran C, Lheureux S, Gien LT.

Gynecol Oncol. 2023 May 12;174:129-132. doi: 10.1016/j.ygyno.2023.05.003. Online ahead of print.

 

Learn more Learn more
Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women. PMID: 37308461

Lee YJ, Kim JS, Jo JC, Kim Y, Im HS, Kim H, Koh S, Min YJ, Park SH, Ahn JW, Choi Y.

Eur J Haematol. 2023 Jun 12. doi: 10.1111/ejh.14027. Online ahead of print.

PMID: 37308461

Learn more Learn more
Clinical course of multiple sclerosis and patient experiences during breast cancer treatment. PMID: 37291903

Nylander AN, Singh J, Poole S, Anderson A, Marrie RA, Rugo H, Bove R.

Mult Scler. 2023 Jun 8:13524585231175975. doi: 10.1177/13524585231175975. Online ahead of print.

PMID: 37291903

Learn more Learn more
Social isolation and social connectedness among young adult cancer survivors: A systematic review PMID: 37489837

Fox RS, Armstrong GE, Gaumond JS, Vigoureux TFD, Miller CH, Sanford SD, Salsman JM, Katsanis E, Badger TA, Reed DR, Gonzalez BD, Jim HSL, Warner EL, Victorson DE, Oswald LB.

Cancer. 2023 Jul 25. doi: 10.1002/cncr.34934. Online ahead of print.

PMID: 37489837

Learn more Learn more
A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program PMID: 37468569

Palmieri C, Musson A, Harper-Wynne C, Wheatley D, Bertelli G, Macpherson IR, Nathan M, McDowall E, Bhojwani A, Verrill M, Eva J, Doody C, Chowdhury R.

Br J Cancer. 2023 Jul 19. doi: 10.1038/s41416-023-02352-5. Online ahead of print.

PMID: 37468569

Learn more Learn more
Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment PMID: 37561345

Ramalingam K, Clelland E, Rothschild H, Mujir F, Record H, Kaur M, Mukhtar RA.

Ann Surg Oncol. 2023 Aug 10. doi: 10.1245/s10434-023-14075-1. Online ahead of print.

PMID: 37561345

Learn more Learn more
Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care PMID: 37566341

Hill RE, Mercieca-Bebber R, Fardell JE, Wakefield CE, Signorelli C, Webber K, Cohn RJ; ANZCHOG Study Group.

Cancer. 2023 Aug 11. doi: 10.1002/cncr.34984. Online ahead of print.

PMID: 37566341

Learn more Learn more
Primary care practitioners' priorities for improving the timeliness of cancer diagnosis in primary care: a European cluster-based analysis PMID: 37716971

Neves AL, Esteva M, Hoffman R, Harris M.

BMC Health Serv Res. 2023 Sep 16;23(1):997. doi: 10.1186/s12913-023-09891-w.

Learn more Learn more
Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue PMID: 37708581

Wright AA, Poort H, Tavormina A, Schmiege SJ, Matulonis UA, Campos SM, Liu JF, Slivjak ET, Gilmour AL, Salinger JM, Haggerty AF, Arch JJ.

Gynecol Oncol. 2023 Sep 12;177:165-172. doi: 10.1016/j.ygyno.2023.08.020. Online ahead of print.

Learn more Learn more
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement PMID: 37797647

Cui W, Rocconi RP, Thota R, Anderson RA, Bruinooge SS, Comstock IA, Denduluri N, Gassman A, Gralow J, Hutt KJ, Amiri-Kordestani L, Lambertini M, Leighton J, Lu KH, Mostoufi-Moab S, Pollastro T, Pradhan S, Saber H, Schenkel C, Spratt D, Wedam S, Phillips KA.

Lancet Oncol. 2023 Oct;24(10):e415-e423. doi: 10.1016/S1470-2045(23)00390-X.

PMID: 37797647

Learn more Learn more
PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial. PMID: 37813479

Loukovaara M, Bützow R, Staff S, Mäenpää M, Faltinová M, Lassus H, Veijalainen O, Grönvall M, Vaalavirta L, Kuikka E, Haataja M, Urpilainen E, Simojoki M, Anttila M, Auranen A.

Int J Gynecol Cancer. 2023 Oct 9:ijgc-2023-004939. doi: 10.1136/ijgc-2023-004939. Online ahead of print.

PMID: 37813479

Learn more Learn more
Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer PMID: 37917089

McVicker L, Labeit AM, Coupland CAC, Hicks B, Hughes C, McMenamin Ú, McIntosh SA, Murchie P, Cardwell CR.

JAMA Oncol. 2023 Nov 2:e234508. doi: 10.1001/jamaoncol.2023.4508. Online ahead of print.

PMID: 37917089

Learn more Learn more
Medical students' knowledge on cancer predisposition syndromes and attitude toward eHealth PMID: 37934269

Nees J, Struewe F, Schott S.

Arch Gynecol Obstet. 2023 Nov 7. doi: 10.1007/s00404-023-07266-4. Online ahead of print.

PMID: 37934269

Learn more Learn more
Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity PMID: 38060241

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL.

JAMA Oncol. 2023 Dec 7:e235242. doi: 10.1001/jamaoncol.2023.5242. Online ahead of print.

PMID: 38060241

Learn more Learn more
Global burden of 34 cancers among women in 2020 and projections to 2040: Population-based data from 185 countries/territories PMID: 38059753

Bizuayehu HM, Dadi AF, Hassen TA, Ketema DB, Ahmed KY, Kassa ZY, Amsalu E, Kibret GD, Alemu AA, Alebel A, Shifa JE, Assefa Y, Tessema GA, Sarich P, Gebremedhin AF, Bore MG.

Int J Cancer. 2023 Dec 7. doi: 10.1002/ijc.34809. Online ahead of print.

PMID: 38059753

Learn more Learn more
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline PMID: 38206277

Al Sukhun S, Temin S, Barrios CH, Antone NZ, Guerra YC, Mac Gregor MC, Chopra R, Danso MA, Gomez HL, Homian NM, Kandil A, Kithaka B, Koczwara B, Moy B, Nakigudde G, Petracci FE, Rugo HS, El Saghir NS, Arun BK.

JCO Glob Oncol. 2024 Jan;10:e2300285. doi: 10.1200/GO.23.00285.

PMID: 38206277

Learn more Learn more
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer PMID: 38184318

Westermann A, Ottevanger P, Reyners A, Kroep JR, Van Oijen MGH, Lalisang R, Witteveen PO.

Int J Gynecol Cancer. 2024 Jan 6:ijgc-2023-004781. doi: 10.1136/ijgc-2023-004781. Online ahead of print.

PMID: 38184318

Learn more Learn more
Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer PMID: 38342698

Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.

Garbuzenko OB, Sapiezynski J, Girda E, Rodriguez-Rodriguez L, Minko T.

Small. 2024 Feb 11:e2307462. doi: 10.1002/smll.202307462. Online ahead of print.

PMID: 38342698

Learn more Learn more
Contribution of county characteristics to disparities in rural mortality after cancer diagnosis PMID: 38342479

Contribution of county characteristics to disparities in rural mortality after cancer diagnosis.

Franks JA, Davis ES, Bhatia S, Kenzik KM.

Am J Prev Med. 2024 Feb 9:S0749-3797(24)00042-4. doi: 10.1016/j.amepre.2024.02.003. Online ahead of print.

PMID: 38342479

Learn more Learn more
Predicting five-year interval second breast cancer risk in women with prior breast cancer PMID: 38466940

Predicting five-year interval second breast cancer risk in women with prior breast cancer.

Hubbard RA, Su YR, Bowles EJ, Ichikawa L, Kerlikowske K, Lowry KP, Miglioretti DL, Tosteson ANA, Wernli KJ, Lee JM.

J Natl Cancer Inst. 2024 Mar 11:djae063. doi: 10.1093/jnci/djae063. Online ahead of print.

PMID: 38466940

Learn more Learn more
Infertility and risk of postmenopausal breast cancer in the women's health initiative PMID: 38459395

Infertility and risk of postmenopausal breast cancer in the women's health initiative.

Farland LV, Lind KE, Thomson CA, Saquib N, Shadyab AH, Schnatz PF, Robles-Morales R, Qi L, Strickler H, Lane DS, Murugappan G, Roe DJ, Harris HR.

Breast Cancer Res Treat. 2024 Mar 9. doi: 10.1007/s10549-024-07257-2. Online ahead of print.

PMID: 38459395

Learn more Learn more
Correlates of physical activity and sedentary behavior among cancer survivors and cancer-free women: The Women's Health Accelerometry Collaboration PMID: 38573893

Correlates of physical activity and sedentary behavior among cancer survivors and cancer-free women: The Women's Health Accelerometry Collaboration.

Schilsky S, Green Howard A, Moore CC, Cuthbertson CC, Parada H Jr, Lee IM, Di C, LaMonte MJ, Buring JE, Shiroma EJ, LaCroix AZ, Evenson KR.

PLoS One. 2024 Apr 4;19(4):e0301233. doi: 10.1371/journal.pone.0301233. eCollection 2024.

PMID: 38573893

Learn more Learn more
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization PMID: 38568368

BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.

Yerushalmi R, Pomerantz A, Lewin R, Paluch-Shimon S, Soussan-Gutman L, Baehner FL, Voet H, Bareket-Samish A, Kedar I, Goldberg Y, Peretz-Yablonski T, Kadouri L.

Breast Cancer Res Treat. 2024 Apr 3. doi: 10.1007/s10549-024-07271-4. Online ahead of print.

PMID: 38568368

Learn more Learn more
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative PMID: 38736319

Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.

Chlebowski RT, Aragaki AK, Pan K, Simon MS, Neuhouser ML, Haque R, Rohan TE, Wactawski-Wende J, Orchard TS, Mortimer JE, Lane D, Kaunitz AM, Desai P, Wild RA, Barac A, Manson JE.

Cancer. 2024 May 13. doi: 10.1002/cncr.35318. Online ahead of print.

PMID: 38736319

Learn more Learn more
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study PMID: 38735143

Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.

Filippova OT, Boecking K, Broach V, Gardner GJ, Sonoda Y, Chi DS, Zivanovic O, Long Roche K.

Gynecol Oncol. 2024 May 11;187:80-84. doi: 10.1016/j.ygyno.2024.05.009. Online ahead of print.

PMID: 38735143

Learn more Learn more